Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06338995
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-03-25
Brief Title:
A Study of Lebrikizumab LY3650150 in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids CONTRAST-NP
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-25
First Submit QC Date:
March 25 2024
Study First Post Date:
2024-04-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-24
Last Update Post Date:
2024-05-28
Last Update Post Date Type:
ACTUAL